Views & Analysis Genetic testing hopes to speed up drug development in rare e... When it comes to fighting rare diseases, the biggest barrier to overcome is often the lack of knowledge around the condition.
News Aldeyra’s reproxalap for dry eye disease accepted by FDA Biotech Aldeyra Therapeutics has announced that the US Food and Drug Administration (FDA) has accepted its New D
News Welcome to the new pharmaphorum Our website has served us well over the years, but after five years since the last re-design – during which aesthetic standards have changed and website technology has improved